BCL2 and cancer: Cancer cells acquire resistance to apoptosis by overexpression of antiapoptotic proteins (Bcl-2,IAPs, and FLIP) and/or by the downregulation or mutation of proapoptotic proteins (Bax, Apaf-1, caspase-8, and death receptors).